Table 4: Here
Six patients in placebo group and 7 patients in silymarin group experienced gastrointestinal symptoms (e.g., epigastric pain, nausea and vomiting). Three patients in silymarin group and 2 patients in placebo group discontinued the trial due to side effects. Overall, the side effects were tolerable and were managed with advising patients to receive the study drug after meal.